One year after New York’s Medicaid pharmacy benefit transition and 340B drug program “carve-out,” health care providers say the state and federal government have made good on their promise to keep ...

The American Hospital Association's initial comment on the Health Resources and Services Administration’s (HRSA) request for information regarding a 340B Rebate Model Pilot Program.

Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.

New York state is about to disrupt how Medicaid patients receive the prescription drugs they need, which will compromise safety net providers’ ability to provide critical care to underserved New ...

Only a week after calling it quits on a court-halted pilot program, the Trump administration is already revving the engine on how it could test out a rebate model for the 340B Drug Discount program | ...

Good intentions alone are not enough in 340B. Let’s get informed. The good news is that the growing national scrutiny of how the 340B program operates should be seen not as a threat, but as an ...

The Department of Health and Human Services is scrapping the 340B Drug Pricing Program’s rebate model, according to a Thursday court filing. Hospitals are reacting with glee, as the rebate model would ...

All North Dakotans surely know the adage, “If it ain’t broke, don’t fix it.” Well, some North Dakota state lawmakers are test-driving a new concept: “If it is broke, pretend it’s not.” And the ...

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

The 340B Drug Pricing Program was originally constructed so safety-net health care facilities could stretch scarce resources in caring for low-income patients. However, the program has experienced ...